← Open Payments lookup

LEESHA ELLIS-COX: Open Payments

NPI 1598764698 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$137,623 in 350 payments from 16 companies in 2025. Trend: 2023 $153,453 · 2024 $170,443 · 2025 $137,623

Speaker / faculty: $107,396Consulting: $11,940Travel & lodging: $10,534Food & beverage: $7,753
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)83$65,864
Alkermes, Inc.71$54,219
E.R. Squibb & Sons, L.L.C.38$14,214
Vanda Pharmaceuticals Inc.30$863
Neurocrine BioSciences, Inc.26$570
Lundbeck LLC17$369
Teva Pharmaceuticals USA, Inc.20$350
Otsuka America Pharmaceutical, Inc.19$274
Janssen Pharmaceuticals, Inc10$251
Axsome Therapeutics, Inc.8$191

Products named: CAPLYTA, LYBALVI, ARISTADA, COBENFY, FANAPT, INGREZZA, REXULTI, UZEDY.

Industry payments across AL — which companies pay providers there.